Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Current Drug Safety|June 13, 2014
Posterior reversible encephalopathy syndrome in leukemic children: a sensitive issueWala Ben Kridis, Moez Mdhaffer, Yosr Hentati, et al.
Scientific Reports|April 7, 2021
Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancerBoutheina Cherif, Hana Triki, Slim Charfi, et al.
Breast Disease|June 29, 2024
A novel PIK3CA hot-spot mutation in breast cancer patients detected by HRM-COLD-PCR analysisSaoussen Debouki-Joudi, Wala Ben Kridis, Fatma Trifa, et al.
Cancer Immunology, Immunotherapy : CII|October 5, 2021
Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasiaHana Triki, Ken Declerck, Slim Charfi, et al.
Annals of Diagnostic Pathology|September 13, 2022
Discordance in receptor status between primary and metastatic breast cancer and overall survival: A single-center analysisManel Mellouli, Soumaya Graja, Wala Ben Kridis, et al.
Journal of Translational Medicine|March 17, 2021
Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of TunisiaDorra Ben Ayed-Guerfali, Wala Ben Kridis-Rejab, Nihel Ammous-Boukhris, et al.
Molecular Biology Reports|September 9, 2020
Identification of novel candidate genes by exome sequencing in Tunisian familial male breast cancer patientsWala Ben Kridis-Rejeb, Dorra Ben Ayed-Guerfali, Nihel Ammous-Boukhris, et al.
Genes|August 26, 2022
Predominance of the Rare EGFR Mutation p.L861Q in Tunisian Patients with Non-Small Cell Lung CarcinomaRania Abdelmaksoud-Dammak, Nihel Ammous-Boukhris, Amèna Saadallah-Kallel, et al.
BMC Cancer|October 9, 2025
Germline and somatic mutational variants of Tunisian high grade serous ovarian cancer identified by next-generation sequencingNihel Ammous-Boukhris, Rania Abdelmaksoud-Dammak, Wala Ben Kridis, et al.
Pageof 7